Concepedia

Clinical outcomes of patients with resected, early-stage ALK-positive lung cancer

Jamie E. Chaft, Ibiayi Dagogo‐Jack, Fernando C. Santini, Juliana Eng, Beow Y. Yeap, Benjamin Izar, Emily Chin, David R. Jones, Mark G. Kris, Alice T. Shaw,

Lung Cancer · 2018 · 54 citations · 7 references

DOIFull text

Open access

Concepts

References

7

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)

Donavan T. Cheng, Talia Mitchell, Ahmet Zehir et al. · Journal of Molecular Diagnostics · 2015 · 2.2K citations · Full text

, , +14

Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i>

Alice T. Shaw, Beow Y. Yeap, Mari Mino–Kenudson et al. · Journal of Clinical Oncology · 2009 · 1.9K citations · Full text

, , +17

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

Mark G. Kris, Bruce E. Johnson, Lynne D. Berry et al. · JAMA · 2014 · 1.7K citations

, , +17

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

Dora Dias‐Santagata, Sara Akhavanfard, Serena David et al. · EMBO Molecular Medicine · 2010 · 397 citations · Full text

, , +17

ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: A comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features

Yunjian Pan, Yang Zhang, Yuan Li et al. · Lung Cancer · 2014 · 219 citations

, , +17